Why the industry needs to rethink its approach to IRT for smarter trials
With the role of automating patient randomisation and supply management, IRT is a critical backbone for trial execution, yet it…
With the role of automating patient randomisation and supply management, IRT is a critical backbone for trial execution, yet it…
In a clinical development world divided by phases, transitions are critical at every step. The transition from nonclinical testing to…
From the start of Phase I to the completion of Phase III, the average clinical trial cycle has been increasing…
Dr. Zamilpa is the Executive Director of Biomanufacturing and Collaborative Programs at BBG Advanced Therapies, a subsidiary of BioBridge Global…
Clinical trial sponsors are navigating a landscape of increasing complexity. A team of researchers recently set out to explore this…
White space refers to unproductive gaps in drug development, when progress stalls due to scientific barriers or because of process,…
Sharp Services, a leader in pharmaceutical packaging, clinical trial services and sterile manufacturing has announced a $100 million investment across its…
Forced degradation studies simulate harsh conditions to accelerate degradation, helping us uncover potential vulnerabilities in a molecule’s structure and predict…
According to the CDC, an estimated 20.9% of the US adult population experienced chronic pain in 2021, while 6.9% were…
The Interactive Response Technology (IRT) market continues to grow from its humble origins, with one report valuing the IRT market…